Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 138 entries
Sorted by: Best Match Show Resources per page
CyberBridges a model collaboration infrastructure for e-Science

Computer and Information Science and Engineering Minority-Serving Institutions Research Expansion Program AND Program Evaluation

Chatfield D.
GSID: SAsccqDSGp4J
HL Alvarez, D Chatfield, DA Cox… - … Cluster Computing …, 2007 - ieeexplore.ieee.org

The" CyberBridges" pilot project is an innovative model for creating a new generation of scientists and engineers who are capable of fully integrating cyberinfrastructure into the whole educational, professional, and creative process of their respective disciplines. CyberBridges augments graduate...

Cite
Alvarez, H. L., Chatfield, D., Cox, D. A., Crumpler, E., D'Cunha, C., Gutierrez, R., ... & Zhang, C. (2007, May). CyberBridges a model collaboration infrastructure for e-Science. In Seventh IEEE International Symposium on Cluster Computing and the Grid (CCGrid'07) (pp. 65-72). IEEE.
Alvarez, Heidi L., et al. "CyberBridges a model collaboration infrastructure for e-Science." Seventh IEEE International Symposium on Cluster Computing and the Grid (CCGrid'07). IEEE, 2007.
Copy Download .nbib Format: MLA
Discovery of a potentially deleterious variant in TMEM87B in a patient with a hemizygous 2q13 microdeletion suggests a recessive condition characterized by congenital heart disease and restrictive cardiomyopathy.

Cold Spring Harbor molecular case studies

Yu HC, Coughlin CR, Geiger EA, Salvador BJ, Elias ER, Cavanaugh JL, Chatfield KC, Miyamoto SD, Shaikh TH.
PMID: 27148590
Cold Spring Harb Mol Case Stud. 2016 May;2(3):a000844. doi: 10.1101/mcs.a000844.

Restrictive cardiomyopathy (RCM) is a rare cause of heart muscle disease with the highest mortality rate among cardiomyopathy types. The etiology of RCM is poorly understood, although genetic causes have been implicated, and syndromic associations have been described. Here,...

Cite
Yu HC, Coughlin CR, Geiger EA, et al. Discovery of a potentially deleterious variant in TMEM87B in a patient with a hemizygous 2q13 microdeletion suggests a recessive condition characterized by congenital heart disease and restrictive cardiomyopathy. Cold Spring Harb Mol Case Stud. 2016;2(3):a000844doi: 10.1101/mcs.a000844.
Yu, H. C., Coughlin, C. R., Geiger, E. A., Salvador, B. J., Elias, E. R., Cavanaugh, J. L., Chatfield, K. C., Miyamoto, S. D., & Shaikh, T. H. (2016). Discovery of a potentially deleterious variant in TMEM87B in a patient with a hemizygous 2q13 microdeletion suggests a recessive condition characterized by congenital heart disease and restrictive cardiomyopathy. Cold Spring Harbor molecular case studies, 2(3), a000844. https://doi.org/10.1101/mcs.a000844
Yu, Hung-Chun, et al. "Discovery of a potentially deleterious variant in TMEM87B in a patient with a hemizygous 2q13 microdeletion suggests a recessive condition characterized by congenital heart disease and restrictive cardiomyopathy." Cold Spring Harbor molecular case studies vol. 2,3 (2016): a000844. doi: https://doi.org/10.1101/mcs.a000844
Yu HC, Coughlin CR, Geiger EA, Salvador BJ, Elias ER, Cavanaugh JL, Chatfield KC, Miyamoto SD, Shaikh TH. Discovery of a potentially deleterious variant in TMEM87B in a patient with a hemizygous 2q13 microdeletion suggests a recessive condition characterized by congenital heart disease and restrictive cardiomyopathy. Cold Spring Harb Mol Case Stud. 2016 May;2(3):a000844. doi: 10.1101/mcs.a000844. PMID: 27148590; PMCID: PMC4853521.
Copy Download .nbib Format: NLM
Cytokinin Oxidase from Phaseolus vulgaris Callus Tissues : Enhanced in Vitro Activity of the Enzyme in the Presence of Copper-Imidazole Complexes.

Plant physiology

Chatfield JM, Armstrong DJ.
PMID: 16665511
Plant Physiol. 1987 Jul;84(3):726-31. doi: 10.1104/pp.84.3.726.

The effects of metal ions on cytokinin oxidase activity extracted from callus tissues of Phaseolus vulgaris L. cv Great Northern have been examined using an assay based on the oxidation of N(6)-(Delta(2)-isopentenyl)-adenine-2,8-(3)H (i(6) Ade) to adenine (Ade). The addition...

Cite
Chatfield JM, Armstrong DJ. Cytokinin Oxidase from Phaseolus vulgaris Callus Tissues : Enhanced in Vitro Activity of the Enzyme in the Presence of Copper-Imidazole Complexes. Plant Physiol. 1987;84(3):726-31doi: 10.1104/pp.84.3.726.
Chatfield, J. M., & Armstrong, D. J. (1987). Cytokinin Oxidase from Phaseolus vulgaris Callus Tissues : Enhanced in Vitro Activity of the Enzyme in the Presence of Copper-Imidazole Complexes. Plant physiology, 84(3), 726-31. https://doi.org/10.1104/pp.84.3.726
Chatfield, J M, and Armstrong, D J. "Cytokinin Oxidase from Phaseolus vulgaris Callus Tissues : Enhanced in Vitro Activity of the Enzyme in the Presence of Copper-Imidazole Complexes." Plant physiology vol. 84,3 (1987): 726-31. doi: https://doi.org/10.1104/pp.84.3.726
Chatfield JM, Armstrong DJ. Cytokinin Oxidase from Phaseolus vulgaris Callus Tissues : Enhanced in Vitro Activity of the Enzyme in the Presence of Copper-Imidazole Complexes. Plant Physiol. 1987 Jul;84(3):726-31. doi: 10.1104/pp.84.3.726. PMID: 16665511; PMCID: PMC1056659.
Copy Download .nbib Format: NLM
Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease.

Nutrition & metabolism

Powell JJ, Cook WB, Hutchinson C, Tolkien Z, Chatfield M, Pereira DIa, Lomer MC.
PMID: 23320878
Nutr Metab (Lond). 2013 Jan 15;10(1):9. doi: 10.1186/1743-7075-10-9.

BACKGROUND: Iron deficiency anaemia and oral iron supplementation have been associated negatively with quality of life, and with adverse effects, respectively, in subjects with inflammatory bowel disease (IBD). Hence, the risk-benefit ratio of oral iron is not understood in...

Cite
Powell JJ, Cook WB, Hutchinson C, et al. Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease. Nutr Metab (Lond). 2013;10(1):9doi: 10.1186/1743-7075-10-9.
Powell, J. J., Cook, W. B., Hutchinson, C., Tolkien, Z., Chatfield, M., Pereira, D. I. a., & Lomer, M. C. (2013). Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease. Nutrition & metabolism, 10(1), 9. https://doi.org/10.1186/1743-7075-10-9
Powell, Jonathan J, et al. "Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease." Nutrition & metabolism vol. 10,1 (2013): 9. doi: https://doi.org/10.1186/1743-7075-10-9
Powell JJ, Cook WB, Hutchinson C, Tolkien Z, Chatfield M, Pereira DIa, Lomer MC. Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease. Nutr Metab (Lond). 2013 Jan 15;10(1):9. doi: 10.1186/1743-7075-10-9. PMID: 23320878; PMCID: PMC3568053.
Copy Download .nbib Format: NLM
Cystic Fibrosis and Celiac Disease: Both Can Occur Together.

Clinical pediatrics

Pohl JF, Judkins J, Meihls S, Lowichik A, Chatfield BA, McDonald CM.
PMID: 21138852
Clin Pediatr (Phila). 2010 Dec 06; doi: 10.1177/0009922810388512. Epub 2010 Dec 06.

No abstract available.

Cite
Pohl JF, Judkins J, Meihls S, et al. Cystic Fibrosis and Celiac Disease: Both Can Occur Together. Clin Pediatr (Phila). 2010;doi: 10.1177/0009922810388512.
Pohl, J. F., Judkins, J., Meihls, S., Lowichik, A., Chatfield, B. A., & McDonald, C. M. (2010). Cystic Fibrosis and Celiac Disease: Both Can Occur Together. Clinical pediatrics, . https://doi.org/10.1177/0009922810388512
Pohl, John Frederick, et al. "Cystic Fibrosis and Celiac Disease: Both Can Occur Together." Clinical pediatrics vol. (2010). doi: https://doi.org/10.1177/0009922810388512
Pohl JF, Judkins J, Meihls S, Lowichik A, Chatfield BA, McDonald CM. Cystic Fibrosis and Celiac Disease: Both Can Occur Together. Clin Pediatr (Phila). 2010 Dec 06; doi: 10.1177/0009922810388512. Epub 2010 Dec 06. PMID: 21138852.
Copy Download .nbib Format: NLM
Strategies of Dyadic Coping and Self-Regulation in the Family Homes of Chronically Ill Persons: A Qualitative Research Study Using the Emotional Map of the Home Interview Method.

Frontiers in psychology

Sallay V, Martos T, Chatfield SL, Dúll A.
PMID: 30873092
Front Psychol. 2019 Feb 28;10:403. doi: 10.3389/fpsyg.2019.00403. eCollection 2019.

Environmental and emotional self-regulation skills play a critical role in promoting well-being of individuals and in encouraging healthy relationships. However, occurrence of chronic illness in one family member complicates routine dyadic coping processes for the couple. Additionally, according to...

Cite
Sallay V, Martos T, Chatfield SL, et al. Strategies of Dyadic Coping and Self-Regulation in the Family Homes of Chronically Ill Persons: A Qualitative Research Study Using the Emotional Map of the Home Interview Method. Front Psychol. 2019;10:403doi: 10.3389/fpsyg.2019.00403.
Sallay, V., Martos, T., Chatfield, S. L., & Dúll, A. (2019). Strategies of Dyadic Coping and Self-Regulation in the Family Homes of Chronically Ill Persons: A Qualitative Research Study Using the Emotional Map of the Home Interview Method. Frontiers in psychology, 10403. https://doi.org/10.3389/fpsyg.2019.00403
Sallay, Viola, et al. "Strategies of Dyadic Coping and Self-Regulation in the Family Homes of Chronically Ill Persons: A Qualitative Research Study Using the Emotional Map of the Home Interview Method." Frontiers in psychology vol. 10 (2019): 403. doi: https://doi.org/10.3389/fpsyg.2019.00403
Sallay V, Martos T, Chatfield SL, Dúll A. Strategies of Dyadic Coping and Self-Regulation in the Family Homes of Chronically Ill Persons: A Qualitative Research Study Using the Emotional Map of the Home Interview Method. Front Psychol. 2019 Feb 28;10:403. doi: 10.3389/fpsyg.2019.00403. eCollection 2019. PMID: 30873092; PMCID: PMC6403154.
Copy Download .nbib Format: NLM
Atrial fibrillation after cardiac surgery: Prevention and management: The Australasian experience.

Journal of the Saudi Heart Association

Alawami M, Chatfield A, Ghashi R, Walker L.
PMID: 29296063
J Saudi Heart Assoc. 2018 Jan;30(1):40-46. doi: 10.1016/j.jsha.2017.03.008. Epub 2017 Mar 24.

BACKGROUND: Atrial fibrillation (AF) after cardiac surgery is a major health problem that is associated with a significant financial burden. This paper aims to highlight this problem and review the current guidelines in the prevention and management of AF...

Cite
Alawami M, Chatfield A, Ghashi R, et al. Atrial fibrillation after cardiac surgery: Prevention and management: The Australasian experience. J Saudi Heart Assoc. 2017;30(1):40-46doi: 10.1016/j.jsha.2017.03.008.
Alawami, M., Chatfield, A., Ghashi, R., & Walker, L. (2018). Atrial fibrillation after cardiac surgery: Prevention and management: The Australasian experience. Journal of the Saudi Heart Association, 30(1), 40-46. https://doi.org/10.1016/j.jsha.2017.03.008
Alawami, Mohammed, et al. "Atrial fibrillation after cardiac surgery: Prevention and management: The Australasian experience." Journal of the Saudi Heart Association vol. 30,1 (2018): 40-46. doi: https://doi.org/10.1016/j.jsha.2017.03.008
Alawami M, Chatfield A, Ghashi R, Walker L. Atrial fibrillation after cardiac surgery: Prevention and management: The Australasian experience. J Saudi Heart Assoc. 2018 Jan;30(1):40-46. doi: 10.1016/j.jsha.2017.03.008. Epub 2017 Mar 24. PMID: 29296063; PMCID: PMC5744031.
Copy Download .nbib Format: NLM
Perspective: Using Bronchiectasis Action Management Plans for Children With Bronchiectasis-Can It Improve Clinical Care?.

Frontiers in pediatrics

Schutz KL, Marchant JM, Chang AB, Turner C, Chatfield MD, McCallum GB.
PMID: 31737587
Front Pediatr. 2019 Oct 30;7:428. doi: 10.3389/fped.2019.00428. eCollection 2019.

While once thought to be rare, bronchiectasis has been increasing globally over the last 15 years. Bronchiectasis is a major contributor to chronic lung morbidity and mortality but remains a neglected disease in respiratory health globally. Currently, few high-level...

Cite
Schutz KL, Marchant JM, Chang AB, et al. Perspective: Using Bronchiectasis Action Management Plans for Children With Bronchiectasis-Can It Improve Clinical Care?. Front Pediatr. 2019;7:428doi: 10.3389/fped.2019.00428.
Schutz, K. L., Marchant, J. M., Chang, A. B., Turner, C., Chatfield, M. D., & McCallum, G. B. (2019). Perspective: Using Bronchiectasis Action Management Plans for Children With Bronchiectasis-Can It Improve Clinical Care?. Frontiers in pediatrics, 7428. https://doi.org/10.3389/fped.2019.00428
Schutz, Kobi L, et al. "Perspective: Using Bronchiectasis Action Management Plans for Children With Bronchiectasis-Can It Improve Clinical Care?." Frontiers in pediatrics vol. 7 (2019): 428. doi: https://doi.org/10.3389/fped.2019.00428
Schutz KL, Marchant JM, Chang AB, Turner C, Chatfield MD, McCallum GB. Perspective: Using Bronchiectasis Action Management Plans for Children With Bronchiectasis-Can It Improve Clinical Care?. Front Pediatr. 2019 Oct 30;7:428. doi: 10.3389/fped.2019.00428. eCollection 2019. PMID: 31737587; PMCID: PMC6831557.
Copy Download .nbib Format: NLM
Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.

The Cochrane database of systematic reviews

Roberts KE, Adsett IT, Rickett K, Conroy SM, Chatfield MD, Woodward NE.
PMID: 35005781
Cochrane Database Syst Rev. 2022 Jan 10;1:CD013167. doi: 10.1002/14651858.CD013167.pub2.

BACKGROUND: Adjuvant aromatase inhibitors (AI) improve survival compared to tamoxifen in postmenopausal women with hormone receptor-positive stage I to III breast cancer. In approximately half of these women, AI are associated with aromatase inhibitor-induced musculoskeletal symptoms (AIMSS), often described...

Cite
Roberts KE, Adsett IT, Rickett K, et al. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database Syst Rev. 2022;1:CD013167doi: 10.1002/14651858.CD013167.pub2.
Roberts, K. E., Adsett, I. T., Rickett, K., Conroy, S. M., Chatfield, M. D., & Woodward, N. E. (2022). Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. The Cochrane database of systematic reviews, 1CD013167. https://doi.org/10.1002/14651858.CD013167.pub2
Roberts, Kate E, et al. "Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer." The Cochrane database of systematic reviews vol. 1 (2022): CD013167. doi: https://doi.org/10.1002/14651858.CD013167.pub2
Roberts KE, Adsett IT, Rickett K, Conroy SM, Chatfield MD, Woodward NE. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database Syst Rev. 2022 Jan 10;1:CD013167. doi: 10.1002/14651858.CD013167.pub2. PMID: 35005781; PMCID: PMC8743877.
Copy Download .nbib Format: NLM
Machine Learning Emulation of Gravity Wave Drag in Numerical Weather Forecasting.

Journal of advances in modeling earth systems

Chantry M, Hatfield S, Dueben P, Polichtchouk I, Palmer T.
PMID: 34434491
J Adv Model Earth Syst. 2021 Jul;13(7):e2021MS002477. doi: 10.1029/2021MS002477. Epub 2021 Jul 08.

We assess the value of machine learning as an accelerator for the parameterization schemes of operational weather forecasting systems, specifically the parameterization of nonorographic gravity wave drag. Emulators of this scheme can be trained to produce stable and accurate...

Cite
Chantry M, Hatfield S, Dueben P, et al. Machine Learning Emulation of Gravity Wave Drag in Numerical Weather Forecasting. J Adv Model Earth Syst. 2021;13(7):e2021MS002477doi: 10.1029/2021MS002477.
Chantry, M., Hatfield, S., Dueben, P., Polichtchouk, I., & Palmer, T. (2021). Machine Learning Emulation of Gravity Wave Drag in Numerical Weather Forecasting. Journal of advances in modeling earth systems, 13(7), e2021MS002477. https://doi.org/10.1029/2021MS002477
Chantry, Matthew, et al. "Machine Learning Emulation of Gravity Wave Drag in Numerical Weather Forecasting." Journal of advances in modeling earth systems vol. 13,7 (2021): e2021MS002477. doi: https://doi.org/10.1029/2021MS002477
Chantry M, Hatfield S, Dueben P, Polichtchouk I, Palmer T. Machine Learning Emulation of Gravity Wave Drag in Numerical Weather Forecasting. J Adv Model Earth Syst. 2021 Jul;13(7):e2021MS002477. doi: 10.1029/2021MS002477. Epub 2021 Jul 08. PMID: 34434491; PMCID: PMC8365632.
Copy Download .nbib Format: NLM
Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial.

Trials

Wright H, Harris PNA, Chatfield MD, Lye D, Henderson A, Harris-Brown T, Donaldson A, Paterson DL.
PMID: 34876196
Trials. 2021 Dec 07;22(1):889. doi: 10.1186/s13063-021-05870-w.

BACKGROUND: Increasing rates of antibiotic resistance in Gram-negative organisms due to the presence of extended-spectrum beta-lactamases (ESBL), hyperproduction of AmpC enzymes, carbapenemases and other mechanisms of resistance are identified in common hospital- and healthcare-associated pathogens including Enterobacteriaceae, Pseudomonas aeruginosa...

Cite
Wright H, Harris PNA, Chatfield MD, et al. Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial. Trials. 2021;22(1):889doi: 10.1186/s13063-021-05870-w.
Wright, H., Harris, P. N. A., Chatfield, M. D., Lye, D., Henderson, A., Harris-Brown, T., Donaldson, A., & Paterson, D. L. (2021). Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial. Trials, 22(1), 889. https://doi.org/10.1186/s13063-021-05870-w
Wright, Hugh, et al. "Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial." Trials vol. 22,1 (2021): 889. doi: https://doi.org/10.1186/s13063-021-05870-w
Wright H, Harris PNA, Chatfield MD, Lye D, Henderson A, Harris-Brown T, Donaldson A, Paterson DL. Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial. Trials. 2021 Dec 07;22(1):889. doi: 10.1186/s13063-021-05870-w. PMID: 34876196; PMCID: PMC8649313.
Copy Download .nbib Format: NLM
Ibrutinib as a potential therapeutic for cocaine use disorder.

Translational psychiatry

Huggett SB, Hatfield JS, Walters JD, McGeary JE, Welsh JW, Mackay TFC, Anholt RRH, Palmer RHC.
PMID: 34880215
Transl Psychiatry. 2021 Dec 08;11(1):623. doi: 10.1038/s41398-021-01737-5.

Cocaine use presents a worldwide public health problem with high socioeconomic cost. No current pharmacologic treatments are available for cocaine use disorder (CUD) or cocaine toxicity. To explore pharmaceutical treatments for tthis disorder and its sequelae we analyzed gene...

Cite
Huggett SB, Hatfield JS, Walters JD, et al. Ibrutinib as a potential therapeutic for cocaine use disorder. Transl Psychiatry. 2021;11(1):623doi: 10.1038/s41398-021-01737-5.
Huggett, S. B., Hatfield, J. S., Walters, J. D., McGeary, J. E., Welsh, J. W., Mackay, T. F. C., Anholt, R. R. H., & Palmer, R. H. C. (2021). Ibrutinib as a potential therapeutic for cocaine use disorder. Translational psychiatry, 11(1), 623. https://doi.org/10.1038/s41398-021-01737-5
Huggett, Spencer B, et al. "Ibrutinib as a potential therapeutic for cocaine use disorder." Translational psychiatry vol. 11,1 (2021): 623. doi: https://doi.org/10.1038/s41398-021-01737-5
Huggett SB, Hatfield JS, Walters JD, McGeary JE, Welsh JW, Mackay TFC, Anholt RRH, Palmer RHC. Ibrutinib as a potential therapeutic for cocaine use disorder. Transl Psychiatry. 2021 Dec 08;11(1):623. doi: 10.1038/s41398-021-01737-5. PMID: 34880215; PMCID: PMC8654982.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 138 entries